Intuitive Surgical Debt to Equity Ratio 2006-2018 | ISRG
Current and historical debt to equity ratio values for Intuitive Surgical (ISRG) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Intuitive Surgical debt/equity for the three months ending September 30, 2018 was 0.00.
| Intuitive Surgical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-09-30 | $0.00B | $6.29B | 0.00 |
| 2018-06-30 | $0.00B | $5.87B | 0.00 |
| 2018-03-31 | $0.00B | $5.51B | 0.00 |
| 2017-12-31 | $0.00B | $4.78B | 0.00 |
| 2017-09-30 | $0.00B | $4.96B | 0.00 |
| 2017-06-30 | $0.00B | $4.52B | 0.00 |
| 2017-03-31 | $0.00B | $4.13B | 0.00 |
| 2016-12-31 | $0.00B | $5.78B | 0.00 |
| 2016-09-30 | $0.00B | $5.54B | 0.00 |
| 2016-06-30 | $0.00B | $5.18B | 0.00 |
| 2016-03-31 | $0.00B | $4.75B | 0.00 |
| 2015-12-31 | $0.00B | $4.32B | 0.00 |
| 2015-09-30 | $0.00B | $4.12B | 0.00 |
| 2015-06-30 | $0.00B | $3.79B | 0.00 |
| 2015-03-31 | $0.00B | $3.59B | 0.00 |
| 2014-12-31 | $0.00B | $3.38B | 0.00 |
| 2014-09-30 | $0.00B | $3.08B | 0.00 |
| 2014-06-30 | $0.00B | $2.82B | 0.00 |
| 2014-03-31 | $0.00B | $3.66B | 0.00 |
| 2013-12-31 | $0.00B | $3.50B | 0.00 |
| 2013-09-30 | $0.00B | $3.26B | 0.00 |
| 2013-06-30 | $0.00B | $3.72B | 0.00 |
| 2013-03-31 | $0.00B | $3.77B | 0.00 |
| 2012-12-31 | $0.00B | $3.58B | 0.00 |
| 2012-09-30 | $0.00B | $3.29B | 0.00 |
| 2012-06-30 | $0.00B | $3.18B | 0.00 |
| 2012-03-31 | $0.00B | $2.93B | 0.00 |
| 2011-12-31 | $0.00B | $2.65B | 0.00 |
| 2011-09-30 | $0.00B | $2.37B | 0.00 |
| 2011-06-30 | $0.00B | $2.29B | 0.00 |
| 2011-03-31 | $0.00B | $2.23B | 0.00 |
| 2010-12-31 | $0.00B | $2.04B | 0.00 |
| 2010-09-30 | $0.00B | $2.01B | 0.00 |
| 2010-06-30 | $0.00B | $1.92B | 0.00 |
| 2010-03-31 | $0.00B | $1.77B | 0.00 |
| 2009-12-31 | $0.00B | $1.54B | 0.00 |
| 2009-09-30 | $0.00B | $1.39B | 0.00 |
| 2009-06-30 | $0.00B | $1.27B | 0.00 |
| 2009-03-31 | $0.00B | $1.18B | 0.00 |
| 2008-12-31 | $0.00B | $1.27B | 0.00 |
| 2008-09-30 | $0.00B | $1.18B | 0.00 |
| 2008-06-30 | $0.00B | $1.07B | 0.00 |
| 2008-03-31 | $0.00B | $0.98B | 0.00 |
| 2007-12-31 | $0.00B | $0.89B | 0.00 |
| 2007-09-30 | $0.00B | $0.80B | 0.00 |
| 2007-06-30 | $0.00B | $0.71B | 0.00 |
| 2007-03-31 | $0.00B | $0.64B | 0.00 |
| 2006-12-31 | $0.00B | $0.59B | 0.00 |
| 2006-09-30 | $0.00B | $0.54B | 0.00 |
| 2006-06-30 | $0.00B | $0.50B | 0.00 |
| 2006-03-31 | $0.00B | $0.47B | 0.00 |
| 2005-12-31 | $0.00B | $0.44B | 0.00 |
| 2005-09-30 | $0.00B | $0.38B | 0.00 |
| 2005-06-30 | $0.00B | $0.35B | 0.00 |
| 2005-03-31 | $0.00B | $0.33B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $59.217B | $3.129B |
| Intuitive Surgical, Inc. is the global technology leader in minimally invasive robotic-assisted surgery. The Company's da Vinci Surgical System enables surgeons to operate minimally invasively through a few small incisions or the belly button from a nearby ergonomic console. The da Vinci System features a magnified 3D HD vision system and tiny wristed instruments that bend and rotate far greater than the human hand. As a result of this technology, da Vinci enables surgeons to operate with enhanced vision, precision and control. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $97.045B | 22.61 |
| Edwards Lifesciences (EW) | United States | $32.551B | 34.83 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.608B | 16.66 |
| IDEXX Laboratories (IDXX) | United States | $17.365B | 49.60 |
| ABIOMED (ABMD) | United States | $14.403B | 103.49 |
| DexCom (DXCM) | United States | $12.274B | 0.00 |
| Teleflex (TFX) | United States | $12.055B | 27.37 |
| Hologic (HOLX) | United States | $11.459B | 18.80 |
| Varian Medical Systems (VAR) | United States | $10.872B | 26.93 |
| STERIS (STE) | United Kingdom | $10.002B | 26.54 |
| LivaNova (LIVN) | United Kingdom | $6.106B | 39.19 |
| Masimo (MASI) | United States | $5.811B | 37.68 |
| Globus Medical (GMED) | United States | $5.097B | 31.95 |
| Penumbra (PEN) | United States | $4.712B | 284.52 |
| Integra LifeSciences Holdings (IART) | United States | $4.624B | 22.52 |
| Wright Medical Group (WMGI) | Netherlands | $3.695B | 0.00 |
| Cantel Medical (CMD) | United States | $3.586B | 36.13 |
| Inogen (INGN) | United States | $3.026B | 65.32 |
| Integer Holdings (ITGR) | United States | $2.776B | 23.23 |
| Halyard Health (AVNS) | United States | $2.304B | 20.76 |
| Glaukos (GKOS) | United States | $2.142B | 0.00 |
| OPKO Health (OPK) | United States | $1.993B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.921B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.535B | 0.00 |
| AxoGen (AXGN) | United States | $1.225B | 0.00 |
| Nevro (NVRO) | United States | $1.217B | 0.00 |
| Luminex (LMNX) | United States | $1.204B | 43.56 |
| Natus Medical (BABY) | United States | $1.146B | 24.06 |
| Pacific Biosciences Of California (PACB) | United States | $1.123B | 0.00 |
| Orthofix (OFIX) | United States | $1.108B | 32.01 |
| CryoLife (CRY) | United States | $1.094B | 95.93 |
| Tactile Systems Technology (TCMD) | United States | $1.081B | 172.12 |
| Intersect ENT (XENT) | United States | $0.952B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.806B | 28.19 |
| Accelerate Diagnostics (AXDX) | United States | $0.782B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.768B | 45.43 |
| ViewRay (VRAY) | United States | $0.663B | 0.00 |
| Veracyte (VCYT) | United States | $0.562B | 0.00 |
| Sientra (SIEN) | United States | $0.522B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.419B | 0.00 |
| Accuray (ARAY) | United States | $0.408B | 0.00 |
| SI-BONE INC (SIBN) | United States | $0.407B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.374B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.365B | 0.00 |
| Nuvectra (NVTR) | United States | $0.325B | 0.00 |
| Fluidigm (FLDM) | United States | $0.322B | 0.00 |
| Neuronetics (STIM) | United States | $0.318B | 0.00 |
| IRadimed (IRMD) | United States | $0.299B | 78.06 |
| SeaSpine Holdings (SPNE) | United States | $0.285B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.280B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.278B | 43.80 |
| Pulse Biosciences (PLSE) | United States | $0.215B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.204B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.189B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.127B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.123B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.103B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.098B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.094B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.090B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.077B | 0.00 |
| EDAP TMS (EDAP) | France | $0.076B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.072B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.068B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.066B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.046B | 0.00 |
| Vermillion (VRML) | United States | $0.038B | 0.00 |
| ConforMIS (CFMS) | United States | $0.033B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.028B | 0.00 |
| Neovasc (NVCN) | Canada | $0.027B | 0.00 |
| PAVmed (PAVM) | United States | $0.027B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.027B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.021B | 0.00 |
| Dynatronics (DYNT) | United States | $0.021B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.015B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.015B | 0.00 |
| Presbia (LENS) | Ireland | $0.012B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.010B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.009B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.007B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Amedica (SINT) | United States | $0.003B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
